Why this startup is taking its AI to predict breast-cancer risk directly to patients
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk
Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
The reason your healthcare premiums are skyrocketing? AI.
Rising healthcare costs are hammering Americans, and now artificial intelligence is raising the price tag even more. The…
What ‘Asian glow’ means for patients’ long-term health and drinking
I was 8 years old, sitting at dinner with my grandparents, watching Gong Gong’s face turn bright red…
The new GLP-1 weight-loss pill vs. the shot: a doctor’s answer on oral Wegovy
FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
Older Americans have dementia without knowing—experts reveal signs to watch
A recent study indicated that older Americans may either have dementia diagnoses without knowing or may not self-report…
Reddit menopause forums may be capturing what doctors miss
In forums on Reddit, women share tales of having perimenopause and menopause symptoms misdiagnosed or dismissed as mental…
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China
HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
‘It’s a bit odd at first’: The robot helping with NHS health checks
Ged Cashley suffered a cardiac arrest in 2018 and now has annual checks to monitor his health. The…
EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
The new GLP-1 weight-loss pill vs. the shot: A doctor’s honest answer on oral Wegovy
FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
FDA warns on compounded GLP-1 weight loss drugs
The FDA and doctors are warning patients away from compounded versions of popular weight loss drugs, citing safety…